475 related articles for article (PubMed ID: 19879059)
21. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
Rangarajan R; Subramanian S; Gopalakrishnan K
Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
[TBL] [Abstract][Full Text] [Related]
22. Modeling normal tissue complication probability from repetitive computed tomography scans during fractionated high-dose-rate brachytherapy and external beam radiotherapy of the uterine cervix.
Dale E; Hellebust TP; Skjønsberg A; Høgberg T; Olsen DR
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):963-71. PubMed ID: 10863066
[TBL] [Abstract][Full Text] [Related]
23. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
24. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
[TBL] [Abstract][Full Text] [Related]
25. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
[TBL] [Abstract][Full Text] [Related]
26. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
[TBL] [Abstract][Full Text] [Related]
28. Can point doses predict volumetric dose to rectum and bladder: a CT-based planning study in high dose rate intracavitary brachytherapy of cervical carcinoma?
Patil VM; Patel FD; Chakraborty S; Oinam AS; Sharma SC
Br J Radiol; 2011 May; 84(1001):441-8. PubMed ID: 21511749
[TBL] [Abstract][Full Text] [Related]
29. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
Gao M; Albuquerque K; Chi A; Rusu I
Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
[TBL] [Abstract][Full Text] [Related]
30. Brachytherapy dose received by bladder and rectum in patients with inoperable cervical cancer: CT-based 3D view.
Marošević G; Osmić H; Fazlić S; Mileusnić D; Babić J
Acta Med Acad; 2013; 42(1):83-4. PubMed ID: 23735071
[No Abstract] [Full Text] [Related]
31. A dosimetric comparison of two high-dose-rate brachytherapy planning systems in cervix cancer: standardized template planning vs. computerized treatment planning.
Patone H; Souhami L; Parker W; Evans M; Duclos M; Portelance L
Brachytherapy; 2008; 7(3):254-9. PubMed ID: 18579447
[TBL] [Abstract][Full Text] [Related]
32. Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position.
Nkiwane KS; Pötter R; Fokdal LU; Hoskin P; Pearcey R; Segedin B; Mahantshetty U; Kirisits C
Brachytherapy; 2015; 14(2):252-9. PubMed ID: 25530424
[TBL] [Abstract][Full Text] [Related]
33. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
34. Inter fraction variations in rectum and bladder volumes and dose distributions during high dose rate brachytherapy treatment of the uterine cervix investigated by repetitive CT-examinations.
Hellebust TP; Dale E; Skjønsberg A; Olsen DR
Radiother Oncol; 2001 Sep; 60(3):273-80. PubMed ID: 11514007
[TBL] [Abstract][Full Text] [Related]
35. Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.
Levitchi M; Charra-Brunaud C; Quetin P; Haie-Meder C; Kerr C; Castelain B; Delannes M; Thomas L; Desandes E; Peiffert D
Radiother Oncol; 2012 Jun; 103(3):314-21. PubMed ID: 22633813
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
[TBL] [Abstract][Full Text] [Related]
37. Bladder-Rectum Spacer Balloon versus Vaginal Gauze Packing in High Dose Rate Brachytherapy in Cervical Cancer: A Randomised Study. Part II.
Rai B; Patel FD; Chakraborty S; Kapoor R; Sharma SC; Kumaravelu S; Raghukumar P; Aprem AS
Clin Oncol (R Coll Radiol); 2015 Dec; 27(12):713-9. PubMed ID: 26144319
[TBL] [Abstract][Full Text] [Related]
38. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
[TBL] [Abstract][Full Text] [Related]
39. A prospective study to assess the bladder distension effects on dosimetry in intracavitary brachytherapy of cervical cancer via computed tomography-assisted techniques.
Sun LM; Huang HY; Huang EY; Wang CJ; Ko SF; Lin H; Song JC
Radiother Oncol; 2005 Oct; 77(1):77-82. PubMed ID: 15885826
[TBL] [Abstract][Full Text] [Related]
40. Computed axial tomography tandem and ovoids (CATTO) dosimetry: three-dimensional assessment of bladder and rectal doses.
Gebara WJ; Weeks KJ; Hahn CA; Montana GS; Anscher MS
Radiat Oncol Investig; 1998; 6(6):268-75. PubMed ID: 9885943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
